(Q40564847)

English

Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour-reactive effector cells in vivo

scientific article published on May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour-reactive effector cells in vivo (English)

1 reference

Europe PubMed Central

21 September 2017

1 reference

based on heuristic

inferred from title

author name string

Xiaocai Yan

1

1 reference

Europe PubMed Central

21 September 2017

Bryon D Johnson

2

1 reference

Europe PubMed Central

21 September 2017

Rimas J Orentas

3

1 reference

Europe PubMed Central

21 September 2017

publication date

1 May 2004

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

112

1 reference

Europe PubMed Central

21 September 2017

105-116

1 reference

Europe PubMed Central

21 September 2017

1

1 reference

Europe PubMed Central

21 September 2017

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Transfection of the mouse ICAM-1 gene into murine neuroblastoma enhances susceptibility to lysis, reduces in vivo tumorigenicity and decreases ICAM-2-dependent killing.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Dual expression of CD80 and CD86 produces a tumor vaccine superior to single expression of either molecule.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Cutting edge: naive T cells masquerading as memory cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

The regulation of exogenous and endogenous class I MHC genes in a human tumor cell line, K562.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Control of NKT cell differentiation by tissue-specific microenvironments.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Role of 4-1BB (CD137) in the functional activation of cord blood CD28(-)CD8(+) T cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Therapeutic vaccination with tumor cells that engage CD137.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782467

4 November 2018

4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782467

4 November 2018

Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782467

4 November 2018

Interleukin-2 gene transfer into murine neuroblastoma decreases tumorigenicity and enhances systemic immunity causing regression of preestablished retroperitoneal tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782467

4 November 2018

Treatment of neuroblastoma patients with antiganglioside GD2 antibody plus interleukin-2 induces antibody-dependent cellular cytotoxicity against neuroblastoma detected in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782467

4 November 2018

Human class II major histocompatibility complex gene transfer into murine neuroblastoma leads to loss of tumorigenicity, immunity against subsequent tumor challenge, and elimination of microscopic preestablished tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782467

4 November 2018

Class I (H-2Kb) gene transfection reduces susceptibility of YAC-1 lymphoma targets to natural killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782467

4 November 2018

Immunological Evaluation of Pediatric Cancer Patients Receiving Recombinant Interleukin-2 in a Phase I Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782467

4 November 2018

Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Large-scale production of CD4+ T cells from HIV-1-infected donors after CD3/CD28 costimulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01853.X

21 January 2018

Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15096190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune-mediated regression of 'metastatic' neuroblastoma in the liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/15096190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective immunization against neuroblastoma using double-transduced tumor cells secreting GM-CSF and interferon-gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15096190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-efficiency transduction of freshly isolated human tumor cells using adenoviral interleukin-2 vectors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15096190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/15096190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2567.2004.01853.X

1 reference

Europe PubMed Central

21 September 2017

release_2scmmrcacjfotnoa7yin632w4i

1 reference

https://api.fatcat.wiki/v0/release/2scmmrcacjfotnoa7yin632w4i

24 November 2022

based on heuristic

mapped directly with Wikidata item

0 references

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40564847&oldid=1900598975"